ConductScience.org, home

Paper29655451

Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.

Rivner MH and 4 others. Neurol Clin, 2018. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies. Papers, record 29655451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29655451

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.
PubMed
Journal
Neurol Clin
PubMed
Year
2018
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
1.51
iCite
Revised in PubMed
2019-08-27
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rivner MHMichael H
2Pasnoor MMamatha
3Dimachkie MMMazen M
4Barohn RJRichard J
5Mei LLin

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AutoantibodiesMajor topic
AutoantigensMajor topic
Myasthenia GravisMajor topic
Receptor Protein-Tyrosine KinasesMajor topic
Receptors, CholinergicMajor topic
Humans
Neuromuscular Junction
Phenotype

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AG051510NIA NIH HHSUnited StatesR01AG051510PubMed and NIHNIH RePORTER
R01 NS090083NINDS NIH HHSUnited StatesR01NS090083PubMed and NIHNIH RePORTER

Download CSV of grants

References162

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17675108Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn-deficient mice.Nature1995https://conductscience.org/library/papers/7675108PubMed
26652683Crosslinking of proteins in acetylcholine receptor-rich membranes: association between the beta-subunit and the 43 kd subsynaptic protein.Cell1983https://conductscience.org/library/papers/6652683PubMed
312929188Rapsyn mutations in myasthenic syndrome due to impaired receptor clustering.Muscle Nerve2003https://conductscience.org/library/papers/12929188PubMed
43170600Identification of the mouse muscle 43,000-dalton acetylcholine receptor-associated protein (RAPsyn) by cDNA cloning.J Biol Chem1988https://conductscience.org/library/papers/3170600PubMed
521565192Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice.Exp Neurol2011https://conductscience.org/library/papers/21565192PubMed
624504626Treatment of MuSK-Associated Myasthenia Gravis.Curr Treat Options Neurol2014https://conductscience.org/library/papers/24504626PubMed
719548060Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy.J Neurol2009https://conductscience.org/library/papers/19548060PubMed
817157556Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.Clin Neurophysiol2007https://conductscience.org/library/papers/17157556PubMed
924825477Electrophysiological profile of the patients with MuSK positive myasthenia gravis.Neurol Res2014https://conductscience.org/library/papers/24825477PubMed
1018378885A transient neonatal myasthenic syndrome with anti-musk antibodies.Neurology2008https://conductscience.org/library/papers/18378885PubMed
1117709714Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.Neurology2007https://conductscience.org/library/papers/17709714PubMed
127546737Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury.Neuron1995https://conductscience.org/library/papers/7546737PubMed
1327170368Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis.Curr Neurol Neurosci Rep2016https://conductscience.org/library/papers/27170368PubMed
1424297891MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/24297891PubMed
1521890498A valid mouse model of AGRIN-associated congenital myasthenic syndrome.Hum Mol Genet2011https://conductscience.org/library/papers/21890498PubMed
1623322599Double-seropositive myasthenia gravis.Muscle Nerve2013https://conductscience.org/library/papers/23322599PubMed
1711231638Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.Nat Med2001https://conductscience.org/library/papers/11231638PubMed
1819063688A comparison of long-term post-thymectomy outcome of anti-AChR-positive, anti-AChR-negative and anti-MuSK-positive patients with non-thymomatous myasthenia gravis.Expert Opin Biol Ther2009https://conductscience.org/library/papers/19063688PubMed
1917533129Musk-antibody positive myasthenia gravis presenting with isolated neck extensor weakness.Neuromuscul Disord2007https://conductscience.org/library/papers/17533129PubMed
2017212617Anti-MuSK-positive myasthenia gravis: neuromuscular transmission failure in facial and limb muscles.Acta Neurol Scand2007https://conductscience.org/library/papers/17212617PubMed

See all 162 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
40584517
Consensus guidelines on the diagnosis and management of myasthenia gravis by the Saudi Arabia Neuromuscular and Electrodiagnostic Medicine and neuromuscular specialists from the Gulf Cooperation Council region.
Ther Adv Neurol Disord2025https://conductscience.org/library/papers/40584517PubMed
40304847High-Dose Steroids, Treatment Escalation, and Healthcare Burden in Myasthenia Gravis: A US Claims-Based Cohort Study.Neurol Ther2025https://conductscience.org/library/papers/40304847PubMed
39387949Treatment of myasthenia gravis in france: A retrospective claims database study (STAMINA).J Neurol2024https://conductscience.org/library/papers/39387949PubMed
39006634Rituximab Therapy for Immune-Mediated Neurological Diseases: Our Experience at a Tertiary Care Centre.Cureus2024https://conductscience.org/library/papers/39006634PubMed
38785143Astragaloside IV protects against autoimmune myasthenia gravis in rats via regulation of mitophagy and apoptosis.Mol Med Rep2024https://conductscience.org/library/papers/38785143PubMed
38748320Myasthenia Gravis Disease Burden and Its Impact on Satisfaction with Life: A Qualitative Survey of Patients' Perspectives in Japan.Neurol Ther2024https://conductscience.org/library/papers/38748320PubMed
36815443The role of Rapsyn in neuromuscular junction and congenital myasthenic syndrome.Biomol Biomed2023https://conductscience.org/library/papers/36815443PubMed
35246057Spotlight on MuSK positive myasthenia gravis: clinical characteristics, treatment and outcomes.BMC Neurol2022https://conductscience.org/library/papers/35246057PubMed
34829445Comparative Analysis of BIOCHIP Mosaic-Based Indirect Immunofluorescence with Enzyme-Linked Immunosorbent Assay for Diagnosing Myasthenia Gravis.Diagnostics (Basel)2021https://conductscience.org/library/papers/34829445PubMed
34599742The Role of Plasma Exchange in the Treatment of Refractory Autoimmune Neurological Diseases: a Narrative Review.J Neuroimmune Pharmacol2021https://conductscience.org/library/papers/34599742PubMed
34143342Disease severity and response to treatment in Iranian patients with myasthenia gravis.Neurol Sci2022https://conductscience.org/library/papers/34143342PubMed
34007311The mitochondrial biogenesis signaling pathway is a potential therapeutic target for myasthenia gravis via energy metabolism (Review).Exp Ther Med2021https://conductscience.org/library/papers/34007311PubMed
33629204Giant cell myositis associated with concurrent myasthenia gravis: a case-based review of the literature.Clin Rheumatol2021https://conductscience.org/library/papers/33629204PubMed
33329368Controversies in Ocular Myasthenia Gravis.Front Neurol2020https://conductscience.org/library/papers/33329368PubMed
32859770Possible implications of dysregulated nicotinic acetylcholine receptor diffusion and nanocluster formation in myasthenia gravis.Neural Regen Res2021https://conductscience.org/library/papers/32859770PubMed
32547365Myasthenia Gravis: From the Viewpoint of Pathogenicity Focusing on Acetylcholine Receptor Clustering, Trans-Synaptic Homeostasis and Synaptic Stability.Front Mol Neurosci2020https://conductscience.org/library/papers/32547365PubMed
32444555Retrospective Analysis of Eculizumab in Patients with Acetylcholine Receptor Antibody-Negative Myasthenia Gravis: A Case Series.J Neuromuscul Dis2020https://conductscience.org/library/papers/32444555PubMed

Download CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29655451

GET https://conductscience.org/api/papers/v1/29655451/references?page=2